MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H15020856

April 15, 2020

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

按C13H22N4O3S计算150mg

化学药品

April 15, 2020

Company Information

Applicant Company

Manufacturing Company

赤峰市红山区东城大街818号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁胶囊 - NMPA 批准文号 | MedPath